The Dutch pharmaceuticals company NV Organon has opened an office in Israel. Until now, the company was represented in Israel by NeoPharm.
Industry sources said after decades of working with an Israeli importer, the company had decided to deepen its involvement in the Israeli market and open an independent office.
The sources said they expected Organon to expand the number of clinical trials conducted in Israel and to enter into strategic agreements with local companies in the field.
Organon manufactures a range of psychiatric, contraceptive and fertility drugs. The company's sales in 2001 totaled $2.14 billion. Organon invests 17% of its revenues in research and development.
Organon was founded in 1923 and is now a unit of the pharmaceuticals division of Akzo Nobel NV, a multinational company based in The Netherlands. Akzo Nobel produces and markets health care products, coatings, chemicals and fibers.